Standout Papers
Immediate Impact
67 standout
Citing Papers
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis
2024 Standout
Works of Heather Hofflich being referenced
A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes
2022 Standout
Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Heather Hofflich | 331 | 571 | 136 | 355 | 18 | 972 | |
| Sung‐Kil Lim | 138 | 400 | 86 | 315 | 20 | 851 | |
| Rochelle Collantes | 119 | 921 | 126 | 327 | 19 | 1.1k | |
| Eric R. Kallwitz | 131 | 719 | 233 | 187 | 33 | 1.1k | |
| Laura Bertoccini | 190 | 337 | 150 | 279 | 38 | 873 | |
| Abdullah Bennakhi | 104 | 377 | 77 | 408 | 27 | 1.1k | |
| Kerry–Lee Milner | 94 | 662 | 99 | 294 | 13 | 968 | |
| Tiziana Rollo | 177 | 359 | 105 | 144 | 17 | 989 | |
| Angela Favuzzi | 82 | 360 | 187 | 246 | 25 | 861 | |
| Angela Luciana Barilli | 58 | 284 | 120 | 249 | 31 | 879 | |
| Sunil Kumar Mishra | 74 | 714 | 227 | 577 | 22 | 1.1k |
All Works
Loading papers...